Because the combination of CY, RT and IT-IC decreased the percentage of Tregs in the tumor and increased the ratio of CD8+ T cells/Tregs, we suggest that reduction of Tregs by CY at the time of immunotherapy and during the course of the treatment contributed to the enhanced antitumor effect. Here, CD8A is linked to neoplasm.